NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, ...
Thanks, Jason, and thanks to all of you who have tuned in for today's call. Since the start of 2024, we've been enrolling ...
Efficacy and Safety of Aromatase Inhibitor Combined with Growth Hormone in Korean Boys with Idiopathic Short Stature: A ...
The 2026 version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report has been published. Key ...
As David Cameron reveals he only discovered he had prostate cancer after his wife made him go for a test, Josh Burt explains ...
Hecla Reports High-Grade Gold Discovery at Midas with Visible Gold Intercepts; Expands Mineralization at Keno Hill and Greens ...
London GP Dr Leen Tannous has shared a video busting myths about blood tests, explaining they don't screen for everything and ...
Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved HYRNUO® (sevabertinib), an oral, reversible, tyrosine kinase inhibitor (TKI), for the treatment of adult patients ...
How Modern Testing Sensitivity and Individual Biology Now Shape Every Best THC Detox Kit DecisionREDMOND, Nov. 19, 2025 ...
Even in areas in the west of Scotland, where we traditionally expect a very high challenge in the autumn, we are still not seeing any significant signs of liver fluke in the first half of November.” ...
Blue-chip stocks saw a third day of losses on Monday as Wall Street's slump continued amid doubts about interest rate cuts, ...
Recent Indian studies estimate that approximately 101 million adults in India are living with diabetes, with an additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback